Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
112 hedge funds and large institutions have $211M invested in Surmodics in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 46 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
16% more call options, than puts
Call options by funds: $29K | Put options by funds: $25K
2% more funds holding
Funds holding: 110 → 112 (+2)
15% less capital invested
Capital invested by funds: $249M → $211M (-$38M)
24% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$1.39M |
| 2 |
TA
Teton Advisors
Rye,
New York
|
+$1.31M |
| 3 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
+$1.09M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.04M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$701K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$2.91M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.45M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$1.28M |
| 4 |
JP Morgan Chase
New York
|
-$1.08M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$841K |
SRDX Hedge Fund Activity: Q3 2014 in Review
112 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2014, worth a combined $211M — down 15% from $249M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SRDX positions and 8 closed out — a net gain of 2 holders — while 35 added to existing stakes and 46 trimmed.
The largest buyer was Trigran Investments, adding an estimated $1.39M. The largest seller was Wells Fargo, cutting an estimated $2.91M.
- 112 institutional investors held Surmodics (SRDX) as of Q3 2014, up from 110 in Q2 2014.
- Funds reported $211M of Surmodics stock for Q3 2014, down 15% quarter-over-quarter.
- 10 funds opened new Surmodics positions in Q3 2014 and 8 closed out, a net change of +2 holders.
- The largest Surmodics buyer in Q3 2014 was Trigran Investments, an estimated $1.39M added.
- The largest Surmodics seller in Q3 2014 was Wells Fargo, an estimated $2.91M sold.
Based on aggregated 13F filings for Q3 2014.